EcoDrugPlus

Urotensin 2 Receptor

Ensembl ID : ENSPSNG00000021043
Gene Symbol: UTS2R
1 Cross references
102 Possible Orthologues:

Utrophin

Ensembl ID : ENSPSNG00000013299
Gene Symbol: UTRN
3 Cross references
251 Possible Orthologues:

Vascular Endothelial Growth Factor A

Ensembl ID : ENSPSNG00000021211
Gene Symbol: VEGFA
1 Cross references
253 Possible Orthologues:

Vitamin D Receptor

Ensembl ID : ENSPSNG00000015833
Gene Symbol: VDR
3 Cross references
458 Possible Orthologues:

Vitamin K Epoxide Reductase Complex Subunit 1

Ensembl ID : ENSPSNG00000010835
Gene Symbol: VKORC1
3 Cross references
190 Possible Orthologues:

Xanthine Dehydrogenase

Ensembl ID : ENSPSNG00000009052
Gene Symbol: XDH
1 Cross references
211 Possible Orthologues:

Ensembl ID : ENSPSNG00000010394
Gene Symbol: -
Cross references: -
316 Possible Orthologues:

Ensembl ID : ENSPSNG00000008980
Gene Symbol: -
Cross references: -
165 Possible Orthologues:

Ensembl ID : ENSPSNG00000010069
Gene Symbol: -
Cross references: -
316 Possible Orthologues:

Ensembl ID : ENSPSNG00000013794
Gene Symbol: -
Cross references: -
221 Possible Orthologues:

Ensembl ID : ENSPSNG00000009964
Gene Symbol: -
Cross references: -
229 Possible Orthologues:

Ensembl ID : ENSPSNG00000008675
Gene Symbol: -
Cross references: -
316 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).